Helvetica Chimica Acta ± Vol. 84 (2001)
1117
6-Chloro-1,4-diphenyl-1H-pyrazolo[3,4-d]pyrimidine [22]: CC (SiO2, hexane/CH2Cl2 1:1). Pale yellow
1
needles (recryst. from hexane/AcOEt). M.p. 184 ± 1868. H-NMR (CDCl3): 7.25 ± 7.72 (m, 6 H, Ph); 8.04 ± 8.32
(m, 4 H, Ph); 8.50 (s, H C(3)).
6-Bromo-1,4-diphenyl-1H-pyrazolo[3,4-d]pyrimidine: CC (SiO2, hexane/CH2Cl2 1:1). Colorless needles
(recryst. from hexane/AcOEt). M.p. 1948. 1H-NMR (CDCl3): 7.28 ± 7.82 (m, 6 H, Ph); 8.06 ± 8.40 (m, 4 H, Ph);
8.51 (s, H C(3)). Anal. calc. for C17H11BrN4: C 58.14, H 3.16, N 15.95; found: C 58.30, H 3.14, N 15.83.
4-Chloro-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine [10]: CC (SiO2, hexane/AcOEt 10 :1). White solid. M.p.
131 ± 1328 ([10]: 126 ± 1278). 1H-NMR (CDCl3): 7.32 ± 7.70 (m, 3 H, Ph); 8.07 ± 8.29 (m, 2 H, Ph); 8.34
(s, H C(3)); 8.87 (s, H C(6)).
4-Bromo-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine [23]: CC (SiO2, hexane/CH2Cl2 1 :1). White solid. M.p.
1
137 ± 1398 ([23]: 1358). H-NMR (CDCl3): 7.32 ± 7.69 (m, 3 H, Ph); 8.06 ± 8.30 (m, 2 H, Ph); 8.27 (s, H C(3));
8.81 (s, H C(6)).
2-Chloroquinoxaline [9]: CC (SiO2, hexane/AcOEt 6 :1). Pale yellow solid. M.p. 47 ± 47.58 ([9]: 46 ± 478).
1H-NMR (CDCl3): 7.67 ± 7.93 (m, 2 arom. H); 7.93 ± 8.23 (m, 2 arom. H); 8.78 (s, H C(3)).
2-Bromoquinoxaline [14]: CC (SiO2, hexane/CH2Cl2 3 :2). Pale yellow solid. M.p. 588 ([14]: 58 ± 598).
1H-NMR (CDCl3): 7.62 ± 7.90 (m, 2 arom. H); 7.90 ± 8.23 (m, 2 arom. H); 8.86 (s, H C(3)).
2-Chloro-4-phenylquinazoline [24]: CC (SiO2, hexane/CH2Cl2 1:1). Pale yellow solid. M.p. 111 ± 1128 ([24]:
1
1138). H-NMR (CDCl3): 7.45 ± 8.28 (m, 9 arom. H).
2-Bromo-4-phenylquinazoline: CC (SiO2, hexane/CH2Cl2 1:1). Colorless needles (recryst. from hexane/
AcOEt). M.p. 130 ± 1318. 1H-NMR (CDCl3): 7.44 ± 8.23 (m, 9 arom. H). Anal. calc. for C14H9BrN2: C 58.97,
H 3.18, N 9.82; found: C 58.79, H 3.13, N 9.80.
4-Chloroquinazoline [24]: CC (SiO2, hexane/AcOEt 8 :1). White solid. M.p. 97 ± 988 ([24]: 96.5 ± 97.58).
1H-NMR (CDCl3): 7.78 (qd, J 8.1, 7.9, H C(6)); 7.91 ± 8.17 (m, H C(7), H C(8)); 8.28 (dd, J 8.1, 0.8,
H
C(5)).
4-Bromoquinazoline: CC (SiO2, hexane/AcOEt 2 :1). Pale orange prisms (recryst. from hexane). M.p. 95 ±
978 (dec.). 1H-NMR (CDCl3): 7.60 ± 8.33 (m, H C(5), H C(6), H C(7), H C(8)); 8.98 (s, H C(2)). Anal.
calc. for C8H5BrN2: C 45.96, H 2.41, N 13.40; found: C 46.33, H 2.62, N 13.73.
5. Iodination of Heteroaromatic Alcohols by Cl/I-Exchange: General Procedure. N-Chlorosuccinimide was
added to a soln. of PPh3 in dioxane and stirred at r.t. for 30 min. Starting material was added to the suspension,
and the mixture was stirred under the Conditions 1 (see below). NaI and a cat. amount of hydroiodic acid were
added to the mixture, and the mixture was stirred under the Conditions 2 (see below). Dioxane was evaporated
and the residue dissolved in CH2Cl2 and alkalinized with Et3N. The crude product was purified with by CC (SiO2).
2-Iodoquinoline [25]: According to the General Procedure (Conditions 1: reflux, 6 h; Conditions 2: reflux,
10 h), from quinolin-2(1H)-one (726 mg, 5.00 mmol), PPh3 (2623 mg, 10.0 mmol), N-chlorosuccinimide
(1335 mg, 10.0 mmol), and NaI (1500 mg, 10.0 mmol): 670 mg (53%) of yellow solid. M.p. 44 ± 458 ([25]: 52 ±
1
538). H-NMR (CDCl3): 7.29 ± 7.90 (m, 5 arom. H); 8.05 (d, J 7.6, 1 arom. H).
4-Iodo-2.6-dimethylpyrimidine [26]: According to the General Procedure (Conditions 1: reflux, 9 h,
Conditions 2, reflux, 9 h), from 2,6-dimethylpyrimidin-4(3H)-one (372 mg, 3.00 mmol), PPh3 (1574 mg,
6.00 mmol), N-chlorosuccinimide (801 mg, 6.00 mmol), and NaI (1800 mg, 12.0 mmol): 421 mg (60%) of white
powder. M.p. 1158 ([26]: 1128). 1H-NMR (CDCl3): 2.40 (s, Me C(2)); 2.65 (s, Me C(6)); 7.48 (s, H C(5)).
4-Iodo-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine: According to the General Procedure (Conditions 1: reflux,
8 h, Conditions 2: r.t. 14 h), from 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one (637 mg, 3.00 mmol), PPh3
(1574 mg, 6.00 mmol), N-chlorosuccinimide (801 mg, 6.00 mmol), and NaI (900 mg, 6.00 mmol): 300 mg (31%)
1
of white powder (recryst. from hexane/AcOEt). M.p. 1658. H-NMR (CDCl3): 7.24 ± 7.74 (m, 3 H, Ph); 7.99 ±
8.34 (m, 2 H, Ph); 8.11 (s, H C(3)); 8.72 (s, H C(6)). Anal. calc. for C11H7IN4: C 41.02, H 2.19, N 17.39; found:
C 41.07, H 2.18, N 17.21.
2-Iodoquinoxaline [10]: According to the General Procedure (Conditions 1: reflux, 10 h; Conditions 2:
reflux, 6 h), from quinoxalin-2(1H)-one (731 mg, 5.00 mmol), PPh3 (2623 mg, 10.0 mmol), N-chlorosuccinimide
(1335 mg, 10.0 mmol), and NaI (3000 mg, 20.0 mmol): pale yellow powder. M.p. 104 ± 1058 ([10]: 104 ± 1058).
1H-NMR (CDCl3): 7.55 ± 7.93 (m, 2 arom. H); 7.93 ± 8.36 (m, 2 arom. H); 8.99 (s, H C(3)).
REFERENCES
[1] P. Froyen, Phosphorus, Sulfur, Silicon, Relat. Elem. 1995, 102, 253.
[2] P. Froyen, Phosphorus, Sulfur, Silicon, Relat. Elem. 1994, 91, 145.